Cleodette 0,03 mg/3 mg apvalkotās tabletes लातविया - लातवियाई - Zāļu valsts aģentūra

cleodette 0,03 mg/3 mg apvalkotās tabletes

actavis group ptc ehf., iceland - ethinylestradiolum, drospirenonum - apvalkotās tabletes - 0,03 mg/3 mg

Cleodette 0,02 mg/3 mg 28 apvalkotās tabletes लातविया - लातवियाई - Zāļu valsts aģentūra

cleodette 0,02 mg/3 mg 28 apvalkotās tabletes

actavis group ptc ehf., iceland - ethinylestradiolum, drospirenonum - apvalkotās tabletes - 0,02 mg/3 mg

Cleodette 0,02 mg/3 mg apvalkotās tabletes लातविया - लातवियाई - Zāļu valsts aģentūra

cleodette 0,02 mg/3 mg apvalkotās tabletes

actavis group ptc ehf., iceland - ethinylestradiolum, drospirenonum - apvalkotās tabletes - 0,02 mg/3 mg

Degarelix Accord यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - prostatas audzēji - citi hormonu antagonisti un tiem līdzīgas vielas - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.